Clara Jane Hendrickson | Asking for more
The push for flibanserin and its treatment of hypoactive sexual dysfunction disorder in women not only makes a mockery of the drug approval process. It marks a dangerous emboldening of the trend towards medicalizing women’s sexuality and a step away from women’s equality in the bedroom.


















